Review
Published on 06 Oct 2021
From Biology to Clinical Practice: Iron Chelation Therapy With Deferasirox
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2021.752192
- 10,632 views
- 16 citations
Type at least 3 characters
2,074 articles
articles
Review
Published on 01 Oct 2021
The Role of the Gut Microbiome in Pathogenesis, Biology, and Treatment of Plasma Cell Dyscrasias
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2021.741376
- 6,447 views
- 11 citations
Original Research
Published on 30 Sep 2021
Patterns of Tyrosine Kinase Inhibitor Utilization in Newly Treated Patients With Chronic Myeloid Leukemia: An Exhaustive Population-Based Study in France
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2021.675609
- 4,120 views
- 11 citations
Review
Published on 30 Sep 2021
Novel Approaches Outside the Setting of Immunotherapy for the Treatment of Multiple Myeloma: The Case of Melflufen, Venetoclax, and Selinexor
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2021.716751
- 6,679 views
- 2 citations
Review
Published on 30 Sep 2021
TIM-3 in Leukemia; Immune Response and Beyond
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2021.753677
- 15,921 views
- 56 citations
Review
Published on 30 Sep 2021
Biomarkers in Acute Myeloid Leukemia: Leveraging Next Generation Sequencing Data for Optimal Therapeutic Strategies
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2021.748250
- 16,464 views
- 14 citations
Case Report
Published on 30 Sep 2021
Case Report: A Novel Activating FLT3 Mutation in Acute Myeloid Leukemia
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2021.728613
- 4,876 views
- 6 citations
Systematic Review
Published on 30 Sep 2021
Molecular Pathogenesis of Chronic Myelomonocytic Leukemia and Potential Molecular Targets for Treatment Approaches
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2021.751668
- 7,466 views
- 8 citations
Review
Published on 28 Sep 2021
Resistance to Hypomethylating Agents in Myelodysplastic Syndrome and Acute Myeloid Leukemia From Clinical Data and Molecular Mechanism
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2021.706030
- 9,411 views
- 24 citations
Original Research
Published on 28 Sep 2021
The Combination of Gefitinib With ATRA and ATO Induces Myeloid Differentiation in Acute Promyelocytic Leukemia Resistant Cells
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2021.686445
- 6,355 views
- 14 citations
Original Research
Published on 28 Sep 2021
Off-Label Use of Thrombopoietin Receptor Agonists: Case Series and Review of the Literature
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2021.680411
- 7,107 views
- 9 citations
Original Research
Published on 27 Sep 2021
Development of a Nomogram for Predicting the Cumulative Incidence of Disease Recurrence of AML After Allo-HSCT
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2021.732088
- 3,670 views
- 4 citations
Original Research
Published on 27 Sep 2021
Detection of Metastatic Tumor Cells in the Bone Marrow Aspirate Smears by Artificial Intelligence (AI)-Based Morphogo System
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2021.742395
- 10,752 views
- 26 citations
Mini Review
Published on 24 Sep 2021
Steering Mast Cells or Their Mediators as a Prospective Novel Therapeutic Approach for the Treatment of Hematological Malignancies
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2021.731323
- 3,454 views
- 5 citations
Review
Published on 23 Sep 2021
A Different View for an Old Disease: NEDDylation and Other Ubiquitin-Like Post-Translational Modifications in Chronic Lymphocytic Leukemia
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2021.729550
- 4,169 views
- 7 citations
Case Report
Published on 23 Sep 2021
Case Report: Ocular Manifestations and Treatments of Ciliary Body Involvement by Lymphoma
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2021.718759
- 3,205 views
- 4 citations
Original Research
Published on 22 Sep 2021
Bortezomib Inhibits Multiple Myeloma Cells by Transactivating ATF3 to Trigger miR-135a-5p- Dependent Apoptosis
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2021.720261
- 5,895 views
- 7 citations
Case Report
Published on 21 Sep 2021
Case Report: Multi-Omics Analysis and CAR-T Treatment of a Chronic Myeloid Leukemia Blast Crisis Case 5 Years After the Discontinuation of TKI
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2021.739871
- 5,202 views
- 9 citations
Original Research
Published on 21 Sep 2021
Inefficacy of Immunosuppressive Therapy for Severe Aplastic Anemia Progressing From Non-SAA: Improved Outcome After Allogeneic Hematopoietic Stem Cell Transplantation
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2021.739561
- 4,947 views
- 4 citations
Original Research
Published on 20 Sep 2021
Somatic Mutations in Oncogenes Are in Chronic Myeloid Leukemia Acquired De Novo via Deregulated Base-Excision Repair and Alternative Non-Homologous End Joining
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2021.744373
- 5,038 views
- 9 citations
Case Report
Published on 16 Sep 2021
Salvage Therapy With Polatuzumab Vedotin, Bendamustine, and Rituximab Prior to Allogeneic Hematopoietic Transplantation in Patients With Aggressive Lymphomas Relapsing After Therapy With Chimeric Antigen Receptor T-Cells—Report on Two Cases
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2021.737645
- 7,454 views
- 6 citations
Case Report
Published on 16 Sep 2021
Safety and Efficacy of Anti-CD19-Chimeric Antigen Receptor T Cell Combined With Programmed Cell Death 1 Inhibitor Therapy in a Patient With Refractory Post-Transplant Lymphoproliferative Disease: Case Report and Literature Review
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2021.726134
- 5,572 views
- 15 citations
Editorial
Published on 15 Sep 2021
Editorial: Novel Treatment Strategies for Myeloproliferative Neoplasms
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2021.762928
- 2,577 views
Case Report
Published on 13 Sep 2021
Comprehensive Clinicopathologic and Molecular Analysis of Mast Cell Leukemia With Associated Hematologic Neoplasm: A Report and In-Depth Study of 5 Cases
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2021.730503
- 3,799 views
- 3 citations